HKMT-I-005

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHKMT-I-005
Drug Alias Namedual histone methyltransferase EZH2 and EHMT2 inhibitor (Imperial College London/Emory University/University of Toronto)HKMT-I-005HKMT-005HKMTI-1-005
ClassificationSmall molecules
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitorsHistone-lysine N-methyltransferase EHMT2 inhibitorsAnticancer protein kinase inhibitors
TargetsHistone-lysine N-methyltransferase EHMT2Histone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of TorontoEmory UniversityImperial College London
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A